In fiscal year 2020, Aurobindo Pharma spent around 0.2 billion Indian rupees on capital expenses for research and development of pharmaceutical drugs. Recurring expenses for R&D of the company were more than 7.4 billion rupees in the same year.
Expenditure on research and development by Aurobindo Pharma Limited from financial year 2017 to 2020, by type (in billion Indian rupees)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Single Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- Aurobindo Pharma's revenue from ARV formulations FY 2013-2020
- Aurobindo Pharma's revenue from growth market formulations FY 2013-2020
- Aurobindo Pharma's revenue from U.S. formulations FY 2013-2020
- Aurobindo Pharma's EBITDA FY 2013-2020
- Aurobindo Pharma's revenue share 2020 by market
- Aurobindo Pharma's net debt to EBITDA ratio FY 2013-2020
- Aurobindo Pharma's net debt to equity ratio FY 2013-2020
- Aurobindo Pharma's EBITDA margin FY 2013-2020
- Aurobindo Pharma's ANDA filings 2019 by therapy
- Dr. Reddy's Laboratories' monthly share trade value at NSE FY 2020
- Dr. Reddy's Laboratories' net worth FY 2014-2020
- Dr. Reddy's Laboratories' return on capital employed FY 2013-2020
- Dr. Reddy's Laboratories' revenue FY 2017-2020 by product segment
- Dr. Reddy's Laboratories' revenue FY 2014-2020
- Dr. Reddy's Laboratories' EBITDA FY 2014-2020
Aurobindo Pharma. (August 4, 2020). Expenditure on research and development by Aurobindo Pharma Limited from financial year 2017 to 2020, by type (in billion Indian rupees) [Graph]. In Statista. Retrieved February 26, 2021, from https://www.statista.com/statistics/997362/india-aurobindo-pharma-expenditure-on-research-and-development-by-type/
Aurobindo Pharma. "Expenditure on research and development by Aurobindo Pharma Limited from financial year 2017 to 2020, by type (in billion Indian rupees) ." Chart. August 4, 2020. Statista. Accessed February 26, 2021. https://www.statista.com/statistics/997362/india-aurobindo-pharma-expenditure-on-research-and-development-by-type/
Aurobindo Pharma. (2020). Expenditure on research and development by Aurobindo Pharma Limited from financial year 2017 to 2020, by type (in billion Indian rupees) . Statista. Statista Inc.. Accessed: February 26, 2021. https://www.statista.com/statistics/997362/india-aurobindo-pharma-expenditure-on-research-and-development-by-type/
Aurobindo Pharma. "Expenditure on Research and Development by Aurobindo Pharma Limited from Financial Year 2017 to 2020, by Type (in Billion Indian Rupees) ." Statista, Statista Inc., 4 Aug 2020, https://www.statista.com/statistics/997362/india-aurobindo-pharma-expenditure-on-research-and-development-by-type/
Aurobindo Pharma, Expenditure on research and development by Aurobindo Pharma Limited from financial year 2017 to 2020, by type (in billion Indian rupees) Statista, https://www.statista.com/statistics/997362/india-aurobindo-pharma-expenditure-on-research-and-development-by-type/ (last visited February 26, 2021)